actin anti actin mouse Search Results


95
Cytoskeleton Inc mouse monoclonal α actinin
(A,B) Cell surface topography revealed by platinum replica EM of non-extracted untreated (A) or 100 µM blebbistatin (BS)-treated cells (B). (C,D) Fluorescence microscopy of phalloidin-stained F-actin and immunostained <t>α-actinin</t> in detergent-extracted untreated (C) or 100 µM blebbistatin-treated cells (D). (E) Fractions of the cell perimeter occupied by lamellipodia and ruffles in untreated cells, cells treated with 75 µM or 100 µM blebbistatin, and cells recovering from treatment with 100 µM blebbistatin for indicated periods of time in minutes. Error bars, SD. (F,G) Fluorescence microscopy of phalloidin-stained F-actin and immunostained vinculin in detergent-extracted untreated (F) or 100 µM blebbistatin-treated (G) cells. Boxed regions in C, D, E, and G are zoomed in bottom panels. Scale bars, 2 µm (A,B) and 20 µm (C,D,F,G).
Mouse Monoclonal α Actinin, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal α actinin/product/Cytoskeleton Inc
Average 95 stars, based on 1 article reviews
mouse monoclonal α actinin - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

95
Sino Biological mouse monoclonal anti β actin antibody
(A,B) Cell surface topography revealed by platinum replica EM of non-extracted untreated (A) or 100 µM blebbistatin (BS)-treated cells (B). (C,D) Fluorescence microscopy of phalloidin-stained F-actin and immunostained <t>α-actinin</t> in detergent-extracted untreated (C) or 100 µM blebbistatin-treated cells (D). (E) Fractions of the cell perimeter occupied by lamellipodia and ruffles in untreated cells, cells treated with 75 µM or 100 µM blebbistatin, and cells recovering from treatment with 100 µM blebbistatin for indicated periods of time in minutes. Error bars, SD. (F,G) Fluorescence microscopy of phalloidin-stained F-actin and immunostained vinculin in detergent-extracted untreated (F) or 100 µM blebbistatin-treated (G) cells. Boxed regions in C, D, E, and G are zoomed in bottom panels. Scale bars, 2 µm (A,B) and 20 µm (C,D,F,G).
Mouse Monoclonal Anti β Actin Antibody, supplied by Sino Biological, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal anti β actin antibody/product/Sino Biological
Average 95 stars, based on 1 article reviews
mouse monoclonal anti β actin antibody - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

93
Valiant Co Ltd mouse monoclonal c4 anti actin
(A,B) Cell surface topography revealed by platinum replica EM of non-extracted untreated (A) or 100 µM blebbistatin (BS)-treated cells (B). (C,D) Fluorescence microscopy of phalloidin-stained F-actin and immunostained <t>α-actinin</t> in detergent-extracted untreated (C) or 100 µM blebbistatin-treated cells (D). (E) Fractions of the cell perimeter occupied by lamellipodia and ruffles in untreated cells, cells treated with 75 µM or 100 µM blebbistatin, and cells recovering from treatment with 100 µM blebbistatin for indicated periods of time in minutes. Error bars, SD. (F,G) Fluorescence microscopy of phalloidin-stained F-actin and immunostained vinculin in detergent-extracted untreated (F) or 100 µM blebbistatin-treated (G) cells. Boxed regions in C, D, E, and G are zoomed in bottom panels. Scale bars, 2 µm (A,B) and 20 µm (C,D,F,G).
Mouse Monoclonal C4 Anti Actin, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal c4 anti actin/product/Valiant Co Ltd
Average 93 stars, based on 1 article reviews
mouse monoclonal c4 anti actin - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

95
Valiant Co Ltd mouse monoclonal antibodies
(A,B) Cell surface topography revealed by platinum replica EM of non-extracted untreated (A) or 100 µM blebbistatin (BS)-treated cells (B). (C,D) Fluorescence microscopy of phalloidin-stained F-actin and immunostained <t>α-actinin</t> in detergent-extracted untreated (C) or 100 µM blebbistatin-treated cells (D). (E) Fractions of the cell perimeter occupied by lamellipodia and ruffles in untreated cells, cells treated with 75 µM or 100 µM blebbistatin, and cells recovering from treatment with 100 µM blebbistatin for indicated periods of time in minutes. Error bars, SD. (F,G) Fluorescence microscopy of phalloidin-stained F-actin and immunostained vinculin in detergent-extracted untreated (F) or 100 µM blebbistatin-treated (G) cells. Boxed regions in C, D, E, and G are zoomed in bottom panels. Scale bars, 2 µm (A,B) and 20 µm (C,D,F,G).
Mouse Monoclonal Antibodies, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal antibodies/product/Valiant Co Ltd
Average 95 stars, based on 1 article reviews
mouse monoclonal antibodies - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

91
Boster Bio mouse monoclonal β actin antibody
(A,B) Cell surface topography revealed by platinum replica EM of non-extracted untreated (A) or 100 µM blebbistatin (BS)-treated cells (B). (C,D) Fluorescence microscopy of phalloidin-stained F-actin and immunostained <t>α-actinin</t> in detergent-extracted untreated (C) or 100 µM blebbistatin-treated cells (D). (E) Fractions of the cell perimeter occupied by lamellipodia and ruffles in untreated cells, cells treated with 75 µM or 100 µM blebbistatin, and cells recovering from treatment with 100 µM blebbistatin for indicated periods of time in minutes. Error bars, SD. (F,G) Fluorescence microscopy of phalloidin-stained F-actin and immunostained vinculin in detergent-extracted untreated (F) or 100 µM blebbistatin-treated (G) cells. Boxed regions in C, D, E, and G are zoomed in bottom panels. Scale bars, 2 µm (A,B) and 20 µm (C,D,F,G).
Mouse Monoclonal β Actin Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal β actin antibody/product/Boster Bio
Average 91 stars, based on 1 article reviews
mouse monoclonal β actin antibody - by Bioz Stars, 2026-03
91/100 stars
  Buy from Supplier

93
Bio-Rad γ actin
Figure 1. Downregulation of β- or <t>γ-actin</t> expression by corresponding shRNAs in MDA-MB-231 breast cancer cells leads to phenotype changes. (A). Immunofluorescent staining of MDA-MB-231 cells with β- or γ-actin downregulation by corresponding shRNAs. Arrowheads mark leading edge with actin enrichment. Bar, 10 µm. (B). Downregulation of cytoplasmic β- or γ-actin in MDA-MB-231 cells. WB analysis. Graphs represent relative actins expression (Mean ± SEM). For cells with shRNA compared with control (β-actin): p = 0.0015 (shRNA to β-actin); p = 0.007 (shRNA to γ-actin); (γ-actin): p = 0.0037 (shRNA to β-actin); p = 0.0048 (shRNA to γ-actin); Mann–Whitney U test, n = 3. Values of p < 0.01 (**) were considered as statistically significant.
γ Actin, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/γ actin/product/Bio-Rad
Average 93 stars, based on 1 article reviews
γ actin - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

94
Bio-Rad mouse monoclonal anti human smooth muscle actin
Figure 1. Downregulation of β- or <t>γ-actin</t> expression by corresponding shRNAs in MDA-MB-231 breast cancer cells leads to phenotype changes. (A). Immunofluorescent staining of MDA-MB-231 cells with β- or γ-actin downregulation by corresponding shRNAs. Arrowheads mark leading edge with actin enrichment. Bar, 10 µm. (B). Downregulation of cytoplasmic β- or γ-actin in MDA-MB-231 cells. WB analysis. Graphs represent relative actins expression (Mean ± SEM). For cells with shRNA compared with control (β-actin): p = 0.0015 (shRNA to β-actin); p = 0.007 (shRNA to γ-actin); (γ-actin): p = 0.0037 (shRNA to β-actin); p = 0.0048 (shRNA to γ-actin); Mann–Whitney U test, n = 3. Values of p < 0.01 (**) were considered as statistically significant.
Mouse Monoclonal Anti Human Smooth Muscle Actin, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal anti human smooth muscle actin/product/Bio-Rad
Average 94 stars, based on 1 article reviews
mouse monoclonal anti human smooth muscle actin - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

96
R&D Systems anti aacs in house
Figure 1. Downregulation of β- or <t>γ-actin</t> expression by corresponding shRNAs in MDA-MB-231 breast cancer cells leads to phenotype changes. (A). Immunofluorescent staining of MDA-MB-231 cells with β- or γ-actin downregulation by corresponding shRNAs. Arrowheads mark leading edge with actin enrichment. Bar, 10 µm. (B). Downregulation of cytoplasmic β- or γ-actin in MDA-MB-231 cells. WB analysis. Graphs represent relative actins expression (Mean ± SEM). For cells with shRNA compared with control (β-actin): p = 0.0015 (shRNA to β-actin); p = 0.007 (shRNA to γ-actin); (γ-actin): p = 0.0037 (shRNA to β-actin); p = 0.0048 (shRNA to γ-actin); Mann–Whitney U test, n = 3. Values of p < 0.01 (**) were considered as statistically significant.
Anti Aacs In House, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti aacs in house/product/R&D Systems
Average 96 stars, based on 1 article reviews
anti aacs in house - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

95
Boster Bio mouse anti β actin
Figure 1. Downregulation of β- or <t>γ-actin</t> expression by corresponding shRNAs in MDA-MB-231 breast cancer cells leads to phenotype changes. (A). Immunofluorescent staining of MDA-MB-231 cells with β- or γ-actin downregulation by corresponding shRNAs. Arrowheads mark leading edge with actin enrichment. Bar, 10 µm. (B). Downregulation of cytoplasmic β- or γ-actin in MDA-MB-231 cells. WB analysis. Graphs represent relative actins expression (Mean ± SEM). For cells with shRNA compared with control (β-actin): p = 0.0015 (shRNA to β-actin); p = 0.007 (shRNA to γ-actin); (γ-actin): p = 0.0037 (shRNA to β-actin); p = 0.0048 (shRNA to γ-actin); Mann–Whitney U test, n = 3. Values of p < 0.01 (**) were considered as statistically significant.
Mouse Anti β Actin, supplied by Boster Bio, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti β actin/product/Boster Bio
Average 95 stars, based on 1 article reviews
mouse anti β actin - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

86
Valiant Co Ltd actin mp biomedicals 08637931
Figure 1. Downregulation of β- or <t>γ-actin</t> expression by corresponding shRNAs in MDA-MB-231 breast cancer cells leads to phenotype changes. (A). Immunofluorescent staining of MDA-MB-231 cells with β- or γ-actin downregulation by corresponding shRNAs. Arrowheads mark leading edge with actin enrichment. Bar, 10 µm. (B). Downregulation of cytoplasmic β- or γ-actin in MDA-MB-231 cells. WB analysis. Graphs represent relative actins expression (Mean ± SEM). For cells with shRNA compared with control (β-actin): p = 0.0015 (shRNA to β-actin); p = 0.007 (shRNA to γ-actin); (γ-actin): p = 0.0037 (shRNA to β-actin); p = 0.0048 (shRNA to γ-actin); Mann–Whitney U test, n = 3. Values of p < 0.01 (**) were considered as statistically significant.
Actin Mp Biomedicals 08637931, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/actin mp biomedicals 08637931/product/Valiant Co Ltd
Average 86 stars, based on 1 article reviews
actin mp biomedicals 08637931 - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier

94
Bio-Rad mouse monoclonal antibody anti human β actin
Figure 1. Downregulation of β- or <t>γ-actin</t> expression by corresponding shRNAs in MDA-MB-231 breast cancer cells leads to phenotype changes. (A). Immunofluorescent staining of MDA-MB-231 cells with β- or γ-actin downregulation by corresponding shRNAs. Arrowheads mark leading edge with actin enrichment. Bar, 10 µm. (B). Downregulation of cytoplasmic β- or γ-actin in MDA-MB-231 cells. WB analysis. Graphs represent relative actins expression (Mean ± SEM). For cells with shRNA compared with control (β-actin): p = 0.0015 (shRNA to β-actin); p = 0.007 (shRNA to γ-actin); (γ-actin): p = 0.0037 (shRNA to β-actin); p = 0.0048 (shRNA to γ-actin); Mann–Whitney U test, n = 3. Values of p < 0.01 (**) were considered as statistically significant.
Mouse Monoclonal Antibody Anti Human β Actin, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal antibody anti human β actin/product/Bio-Rad
Average 94 stars, based on 1 article reviews
mouse monoclonal antibody anti human β actin - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

94
R&D Systems western blot analysis
Figure 1. Downregulation of β- or <t>γ-actin</t> expression by corresponding shRNAs in MDA-MB-231 breast cancer cells leads to phenotype changes. (A). Immunofluorescent staining of MDA-MB-231 cells with β- or γ-actin downregulation by corresponding shRNAs. Arrowheads mark leading edge with actin enrichment. Bar, 10 µm. (B). Downregulation of cytoplasmic β- or γ-actin in MDA-MB-231 cells. WB analysis. Graphs represent relative actins expression (Mean ± SEM). For cells with shRNA compared with control (β-actin): p = 0.0015 (shRNA to β-actin); p = 0.007 (shRNA to γ-actin); (γ-actin): p = 0.0037 (shRNA to β-actin); p = 0.0048 (shRNA to γ-actin); Mann–Whitney U test, n = 3. Values of p < 0.01 (**) were considered as statistically significant.
Western Blot Analysis, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/western blot analysis/product/R&D Systems
Average 94 stars, based on 1 article reviews
western blot analysis - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

Image Search Results


(A,B) Cell surface topography revealed by platinum replica EM of non-extracted untreated (A) or 100 µM blebbistatin (BS)-treated cells (B). (C,D) Fluorescence microscopy of phalloidin-stained F-actin and immunostained α-actinin in detergent-extracted untreated (C) or 100 µM blebbistatin-treated cells (D). (E) Fractions of the cell perimeter occupied by lamellipodia and ruffles in untreated cells, cells treated with 75 µM or 100 µM blebbistatin, and cells recovering from treatment with 100 µM blebbistatin for indicated periods of time in minutes. Error bars, SD. (F,G) Fluorescence microscopy of phalloidin-stained F-actin and immunostained vinculin in detergent-extracted untreated (F) or 100 µM blebbistatin-treated (G) cells. Boxed regions in C, D, E, and G are zoomed in bottom panels. Scale bars, 2 µm (A,B) and 20 µm (C,D,F,G).

Journal: PLoS ONE

Article Title: Functions of Nonmuscle Myosin II in Assembly of the Cellular Contractile System

doi: 10.1371/journal.pone.0040814

Figure Lengend Snippet: (A,B) Cell surface topography revealed by platinum replica EM of non-extracted untreated (A) or 100 µM blebbistatin (BS)-treated cells (B). (C,D) Fluorescence microscopy of phalloidin-stained F-actin and immunostained α-actinin in detergent-extracted untreated (C) or 100 µM blebbistatin-treated cells (D). (E) Fractions of the cell perimeter occupied by lamellipodia and ruffles in untreated cells, cells treated with 75 µM or 100 µM blebbistatin, and cells recovering from treatment with 100 µM blebbistatin for indicated periods of time in minutes. Error bars, SD. (F,G) Fluorescence microscopy of phalloidin-stained F-actin and immunostained vinculin in detergent-extracted untreated (F) or 100 µM blebbistatin-treated (G) cells. Boxed regions in C, D, E, and G are zoomed in bottom panels. Scale bars, 2 µm (A,B) and 20 µm (C,D,F,G).

Article Snippet: The following primary antibodies were used: mouse monoclonal α-actinin (Cytoskeleton), mouse monoclonal vinculin (Sigma), rabbit polyclonal NMII from bovine spleen , rabbit polyclonal mono- (Ser19) or double- (Thr18/Ser19) phosphorylated MRLC (Cell Signaling Technology, a gift from Dr. C. Chen, University of Pennsylvania).

Techniques: Fluorescence, Microscopy, Staining

(1) NMII activation : Inactive NMII molecules diffuse to lamellipodia, where they are activated by double phosphorylation of MRLC. (2) Focal complex formation: Active unpolymerized NMII molecules bind actin filaments in lamellipodia and undergo the retrograde flow with them. If two NMII heads bind different actin filaments, one of which is anchored to a nascent adhesion, the resulting strain stabilizes the nascent adhesion and promotes its transformation to a focal complex. Long filaments in filopodia can encounter more NMII molecules increasing a probability of focal complex formation under filopodial bundles. (3) Assembly of NMII filaments: NMII molecules pulling on actin filaments attached to focal complexes experience a greater load, which triggers tension-dependent NMII polymerization at these sites. (4) Stress fiber formation: Multivalent NMII filaments exert large forces sufficient to promote maturation of focal complexes to focal adhesions. They also cross-link and align disordered actin filaments into bundles producing stress fibers. However, additional events, such as recruitment of α-actinin, are needed for the formation of semi-sarcomeric pattern in stress fibers.

Journal: PLoS ONE

Article Title: Functions of Nonmuscle Myosin II in Assembly of the Cellular Contractile System

doi: 10.1371/journal.pone.0040814

Figure Lengend Snippet: (1) NMII activation : Inactive NMII molecules diffuse to lamellipodia, where they are activated by double phosphorylation of MRLC. (2) Focal complex formation: Active unpolymerized NMII molecules bind actin filaments in lamellipodia and undergo the retrograde flow with them. If two NMII heads bind different actin filaments, one of which is anchored to a nascent adhesion, the resulting strain stabilizes the nascent adhesion and promotes its transformation to a focal complex. Long filaments in filopodia can encounter more NMII molecules increasing a probability of focal complex formation under filopodial bundles. (3) Assembly of NMII filaments: NMII molecules pulling on actin filaments attached to focal complexes experience a greater load, which triggers tension-dependent NMII polymerization at these sites. (4) Stress fiber formation: Multivalent NMII filaments exert large forces sufficient to promote maturation of focal complexes to focal adhesions. They also cross-link and align disordered actin filaments into bundles producing stress fibers. However, additional events, such as recruitment of α-actinin, are needed for the formation of semi-sarcomeric pattern in stress fibers.

Article Snippet: The following primary antibodies were used: mouse monoclonal α-actinin (Cytoskeleton), mouse monoclonal vinculin (Sigma), rabbit polyclonal NMII from bovine spleen , rabbit polyclonal mono- (Ser19) or double- (Thr18/Ser19) phosphorylated MRLC (Cell Signaling Technology, a gift from Dr. C. Chen, University of Pennsylvania).

Techniques: Activation Assay, Transformation Assay

Figure 1. Downregulation of β- or γ-actin expression by corresponding shRNAs in MDA-MB-231 breast cancer cells leads to phenotype changes. (A). Immunofluorescent staining of MDA-MB-231 cells with β- or γ-actin downregulation by corresponding shRNAs. Arrowheads mark leading edge with actin enrichment. Bar, 10 µm. (B). Downregulation of cytoplasmic β- or γ-actin in MDA-MB-231 cells. WB analysis. Graphs represent relative actins expression (Mean ± SEM). For cells with shRNA compared with control (β-actin): p = 0.0015 (shRNA to β-actin); p = 0.007 (shRNA to γ-actin); (γ-actin): p = 0.0037 (shRNA to β-actin); p = 0.0048 (shRNA to γ-actin); Mann–Whitney U test, n = 3. Values of p < 0.01 (**) were considered as statistically significant.

Journal: Molecules

Article Title: Impaired Expression of Cytoplasmic Actins Leads to Chromosomal Instability of MDA-MB-231 Basal-Like Mammary Gland Cancer Cell Line

doi: 10.3390/molecules26082151

Figure Lengend Snippet: Figure 1. Downregulation of β- or γ-actin expression by corresponding shRNAs in MDA-MB-231 breast cancer cells leads to phenotype changes. (A). Immunofluorescent staining of MDA-MB-231 cells with β- or γ-actin downregulation by corresponding shRNAs. Arrowheads mark leading edge with actin enrichment. Bar, 10 µm. (B). Downregulation of cytoplasmic β- or γ-actin in MDA-MB-231 cells. WB analysis. Graphs represent relative actins expression (Mean ± SEM). For cells with shRNA compared with control (β-actin): p = 0.0015 (shRNA to β-actin); p = 0.007 (shRNA to γ-actin); (γ-actin): p = 0.0037 (shRNA to β-actin); p = 0.0048 (shRNA to γ-actin); Mann–Whitney U test, n = 3. Values of p < 0.01 (**) were considered as statistically significant.

Article Snippet: Mouse monoclonal antibodies to: β-actin (MCA5775GA, AbD Serotec); γ-actin (MCA5776GA, AbD Serotec, Raleigh, NC, USA); pan actin (4968, Cell Signaling) were used.

Techniques: Expressing, Staining, shRNA, Control, MANN-WHITNEY

Figure 2. Downregulation of β- or γ-actin expression by corresponding shRNAs in MDA-MB-231 breast cancer cells leads to cell cycle changes. (A). After 6d of β- or γ-actin depletion by corresponding shRNAs MDA-MB-231 cells were stained with propidium iodide. High content analysis of cell cycle distributions of flow cytometric data was performed after 6d of β- or γ-actin depletion by corresponding shRNAs in MDA-MB-231 cells. (B). The effects of β- or γ-actin depletion on quantitative ratio of cells in interphase and different mitotic phases were analyzed by IF cytometry. The Y-axis indicates the number of cells in specific phases. Student’s t-test, n = 3. Values of p < 0.01 (**), and p < 0.05 (*) were considered as statistically significant. (C). The effects of β- or γ-actin depletion on mitotic phases were analyzed by IF cytometry. The pie chart shows the proportion of cells in different phases of mitosis.

Journal: Molecules

Article Title: Impaired Expression of Cytoplasmic Actins Leads to Chromosomal Instability of MDA-MB-231 Basal-Like Mammary Gland Cancer Cell Line

doi: 10.3390/molecules26082151

Figure Lengend Snippet: Figure 2. Downregulation of β- or γ-actin expression by corresponding shRNAs in MDA-MB-231 breast cancer cells leads to cell cycle changes. (A). After 6d of β- or γ-actin depletion by corresponding shRNAs MDA-MB-231 cells were stained with propidium iodide. High content analysis of cell cycle distributions of flow cytometric data was performed after 6d of β- or γ-actin depletion by corresponding shRNAs in MDA-MB-231 cells. (B). The effects of β- or γ-actin depletion on quantitative ratio of cells in interphase and different mitotic phases were analyzed by IF cytometry. The Y-axis indicates the number of cells in specific phases. Student’s t-test, n = 3. Values of p < 0.01 (**), and p < 0.05 (*) were considered as statistically significant. (C). The effects of β- or γ-actin depletion on mitotic phases were analyzed by IF cytometry. The pie chart shows the proportion of cells in different phases of mitosis.

Article Snippet: Mouse monoclonal antibodies to: β-actin (MCA5775GA, AbD Serotec); γ-actin (MCA5776GA, AbD Serotec, Raleigh, NC, USA); pan actin (4968, Cell Signaling) were used.

Techniques: Expressing, Staining, High Content Screening, Cytometry

Figure 3. Karyotypic analysis of MDA-MB-231 breast cancer cells. (A). A representative G-banded karyotype of MDA- MB-231 cell line. (B). Composite G-banded karyotype of the near-triploid cell line MDA-MB-231, showing structural and numerical changes. Arrows point to main chromosomal alterations. Mar—Marker chromosome. (C,D,F,G). The representa- tive chromosome aberrations in β-actin (C,D) and γ-actin (F,G) -depleted MDA-MB-231 cells: dicentric chromosomes (C,F) and acentric fragment (C), ring chromosomes (D,G). Arrows point to aberrations. E, H. Endoreduplication in β-actin (E) and γ-actin (H) -depleted MDA-MB-231 cell.

Journal: Molecules

Article Title: Impaired Expression of Cytoplasmic Actins Leads to Chromosomal Instability of MDA-MB-231 Basal-Like Mammary Gland Cancer Cell Line

doi: 10.3390/molecules26082151

Figure Lengend Snippet: Figure 3. Karyotypic analysis of MDA-MB-231 breast cancer cells. (A). A representative G-banded karyotype of MDA- MB-231 cell line. (B). Composite G-banded karyotype of the near-triploid cell line MDA-MB-231, showing structural and numerical changes. Arrows point to main chromosomal alterations. Mar—Marker chromosome. (C,D,F,G). The representa- tive chromosome aberrations in β-actin (C,D) and γ-actin (F,G) -depleted MDA-MB-231 cells: dicentric chromosomes (C,F) and acentric fragment (C), ring chromosomes (D,G). Arrows point to aberrations. E, H. Endoreduplication in β-actin (E) and γ-actin (H) -depleted MDA-MB-231 cell.

Article Snippet: Mouse monoclonal antibodies to: β-actin (MCA5775GA, AbD Serotec); γ-actin (MCA5776GA, AbD Serotec, Raleigh, NC, USA); pan actin (4968, Cell Signaling) were used.

Techniques: Marker